AbbVie Gets European Medicines Agency's Positive Opinion For Its IMBRUVICA

By: via Benzinga
AbbVie Inc (NYSE: ABBV) disclosed that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.